• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经导管缘对缘修复术后三尖瓣反流患者体重指数的影响。

Impact of body mass index in patients with tricuspid regurgitation after transcatheter edge-to-edge repair.

机构信息

Heart Center Bonn, Department of Medicine II, University Hospital Bonn, Venusberg-Campus 1, 53127, Bonn, Germany.

出版信息

Clin Res Cardiol. 2024 Jan;113(1):156-167. doi: 10.1007/s00392-023-02312-2. Epub 2023 Oct 4.

DOI:10.1007/s00392-023-02312-2
PMID:37792020
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10808352/
Abstract

BACKGROUND

Obesity and underweight represent classical risk factors for outcome in patients treated for cardiovascular disease. This study describes the impact of different body mass index (BMI) categories on 1-year clinical outcome in patients with tricuspid regurgitation (TR) undergoing transcatheter-edge-to-edge repair (TEER).

METHODS

We analyzed 211 consecutive patients (age 78.3 ± 7.2 years, 55.5% female, median EuroSCORE II 9.6 ± 6.7) with tricuspid regurgitation undergoing TEER from June 2015 until May 2021. Patients were prospectively enrolled in our single center registry and were retrospectively analyzed. Patients were stratified according to body mass index (BMI) into 4 groups: BMI < 20 kg/m (underweight), BMI 20.0 to < 25.0 kg/m (normal weight), BMI 25.0 to > 30.0 kg/m (overweight) and BMI ≥ 30 kg/m (obese).

RESULTS

Kaplan-Meier survival curves demonstrated inferior survival for underweight and obese patients, but comparable outcomes for normal and overweight patients (global log rank test, p < 0.01). Cardiovascular death was significantly higher in underweight patients compared to the other groups (24.1% vs. 7.0% vs. 6.3% vs. 6.4%; p < 0.01). Over all, there were comparable rates of bleeding, stroke and myocardial infarction. Multivariable Cox regression analysis (adjusted for age, gender, coronary artery disease, chronic obstructive pulmonary disease, tricuspid annular plane systolic excursion, left-ventricular ejection fraction) confirmed underweight (HR 3.88; 95% CI 1.64-7.66; p < 0.01) and obesity (HR 3.24; 95% CI 1.37-9.16; p < 0.01) as independent risk factors for 1-year all-cause mortality.

CONCLUSIONS

Compared to normal weight and overweight patients, obesity and underweight patients undergoing TEER display significant higher 1-year all-cause mortality.

摘要

背景

肥胖和体重不足是心血管疾病患者治疗结局的经典危险因素。本研究描述了不同体重指数(BMI)类别对行经导管缘对缘修复(TEER)的三尖瓣反流(TR)患者 1 年临床结局的影响。

方法

我们分析了 2015 年 6 月至 2021 年 5 月期间在我们的单中心注册处接受 TEER 的 211 例连续 TR 患者(年龄 78.3±7.2 岁,55.5%为女性,中位数 EuroSCORE II 9.6±6.7)。患者前瞻性入组至我们的单中心注册处,并进行回顾性分析。根据 BMI 将患者分为 4 组:BMI<20 kg/m2(体重不足)、BMI 20.0-<25.0 kg/m2(正常体重)、BMI 25.0-<30.0 kg/m2(超重)和 BMI≥30 kg/m2(肥胖)。

结果

Kaplan-Meier 生存曲线显示体重不足和肥胖患者的生存状况较差,但正常体重和超重患者的结局相似(全局对数秩检验,p<0.01)。与其他组相比,体重不足患者的心血管死亡明显更高(24.1%比 7.0%比 6.3%比 6.4%;p<0.01)。总体而言,各组出血、卒中和心肌梗死的发生率相似。多变量 Cox 回归分析(调整年龄、性别、冠心病、慢性阻塞性肺疾病、三尖瓣环平面收缩期位移、左心室射血分数)证实体重不足(HR 3.88;95%CI 1.64-7.66;p<0.01)和肥胖(HR 3.24;95%CI 1.37-9.16;p<0.01)是 1 年全因死亡率的独立危险因素。

结论

与正常体重和超重患者相比,接受 TEER 的肥胖和体重不足患者 1 年全因死亡率显著更高。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc79/10808352/df502ffd19ed/392_2023_2312_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc79/10808352/986ef7315814/392_2023_2312_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc79/10808352/df743b37c178/392_2023_2312_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc79/10808352/1fb08f5ccf39/392_2023_2312_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc79/10808352/df502ffd19ed/392_2023_2312_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc79/10808352/986ef7315814/392_2023_2312_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc79/10808352/df743b37c178/392_2023_2312_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc79/10808352/1fb08f5ccf39/392_2023_2312_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc79/10808352/df502ffd19ed/392_2023_2312_Fig4_HTML.jpg

相似文献

1
Impact of body mass index in patients with tricuspid regurgitation after transcatheter edge-to-edge repair.经导管缘对缘修复术后三尖瓣反流患者体重指数的影响。
Clin Res Cardiol. 2024 Jan;113(1):156-167. doi: 10.1007/s00392-023-02312-2. Epub 2023 Oct 4.
2
Underweight is associated with inferior short and long-term outcomes after MitraClip implantation: Results from the German TRAnscatheter mitral valve interventions (TRAMI) registry.体重过轻与 MitraClip 植入后的短期和长期预后不良相关:来自德国经导管二尖瓣介入治疗(TRAMI)注册研究的结果。
Am Heart J. 2020 Apr;222:73-82. doi: 10.1016/j.ahj.2019.12.022. Epub 2020 Jan 10.
3
Characteristics and outcomes of patients with atrial versus ventricular secondary tricuspid regurgitation undergoing tricuspid transcatheter edge-to-edge repair - Results from the TriValve registry.经导管三尖瓣缘对缘修复术治疗房间隔与室间隔继发三尖瓣反流患者的特征和结局:TriValve 注册研究结果。
Eur J Heart Fail. 2023 Dec;25(12):2243-2251. doi: 10.1002/ejhf.3075. Epub 2023 Nov 8.
4
Right Ventricular Cardiac Power Index Predicts 1 Year Outcome After Transcatheter Edge-to-Edge-Repair for Severe Tricuspid Valve Regurgitation.经导管缘对缘修复术治疗重度三尖瓣反流 1 年后右心室心搏量指数预测结果。
Am J Cardiol. 2023 Sep 1;202:182-191. doi: 10.1016/j.amjcard.2023.06.071. Epub 2023 Jul 12.
5
Impact of Tricuspid Regurgitation on Outcomes of Mitral Valve Surgery after Transcatheter Edge-to-Edge Repair.经导管缘对缘修复术后三尖瓣反流对二尖瓣手术结局的影响。
Semin Thorac Cardiovasc Surg. 2024;36(1):11-25. doi: 10.1053/j.semtcvs.2022.06.021. Epub 2022 Aug 3.
6
Baseline, procedural and outcome features of patients undergoing transcatheter aortic valve implantation according to different body mass index categories.根据不同的身体质量指数类别,行经导管主动脉瓣植入术患者的基线、操作程序和结果特征。
Minerva Med. 2021 Aug;112(4):474-482. doi: 10.23736/S0026-4806.21.07379-1. Epub 2021 Feb 12.
7
Pulmonary capillary wedge pressure (PCWP) as prognostic indicator in patients undergoing transcatheter valve repair (TTVR) of severe tricuspid regurgitation.肺毛细血管楔压(PCWP)作为严重三尖瓣反流经导管瓣膜修复术(TTVR)患者的预后指标。
Int J Cardiol. 2020 Nov 1;318:32-38. doi: 10.1016/j.ijcard.2020.06.031. Epub 2020 Jun 27.
8
Prevalence and impact of preoperative moderate/severe tricuspid regurgitation on patients undergoing transcatheter aortic valve replacement.术前中重度三尖瓣反流对接受经导管主动脉瓣置换术患者的患病率及影响
Catheter Cardiovasc Interv. 2015 Mar;85(4):677-84. doi: 10.1002/ccd.25512. Epub 2014 Apr 30.
9
Combined Tricuspid and Mitral Versus Isolated Mitral Valve Repair for Severe MR and TR: An Analysis From the TriValve and TRAMI Registries.三尖瓣和二尖瓣联合修复与单纯二尖瓣修复治疗重度 MR 和 TR:来自 TriValve 和 TRAMI 注册研究的分析。
JACC Cardiovasc Interv. 2020 Mar 9;13(5):543-550. doi: 10.1016/j.jcin.2019.10.023. Epub 2020 Jan 15.
10
Combined Mitral and Tricuspid Versus Isolated Mitral Valve Transcatheter Edge-to-Edge Repair in Patients With Symptomatic Valve Regurgitation at High Surgical Risk.高手术风险的有症状瓣膜反流患者的二尖瓣和三尖瓣联合瓣 versus 单纯二尖瓣瓣环成形术。
JACC Cardiovasc Interv. 2018 Jun 25;11(12):1142-1151. doi: 10.1016/j.jcin.2018.04.010.

引用本文的文献

1
Protruding and Ulcerated Aortic Atheromas as Predictors of Periprocedural Ischemic Stroke Post-Transcatheter Aortic Valve Replacement.突出和溃疡的主动脉粥样斑块作为经导管主动脉瓣置换术后围手术期缺血性卒中的预测指标。
JACC Asia. 2025 Feb;5(2):258-269. doi: 10.1016/j.jacasi.2024.10.020. Epub 2024 Dec 31.
2
Prognostic impact of being underweight in patients undergoing mitral TEER: The OCEAN-Mitral registry.二尖瓣经皮缘对缘修复术患者体重过轻的预后影响:OCEAN-Mitral注册研究
ESC Heart Fail. 2025 Feb;12(1):408-417. doi: 10.1002/ehf2.15047. Epub 2024 Sep 23.

本文引用的文献

1
Prognostic Performance of the Surgical TRI-SCORE Risk Score in Patients Undergoing Transcatheter Tricuspid Valve Treatment.经导管三尖瓣治疗患者手术TRI-SCORE风险评分的预后性能
JACC Cardiovasc Interv. 2022 Oct 10;15(19):1996-1998. doi: 10.1016/j.jcin.2022.05.031. Epub 2022 Sep 14.
2
TRI-SCORE: a new risk score for in-hospital mortality prediction after isolated tricuspid valve surgery.TRI-SCORE:一种用于预测孤立性三尖瓣手术后院内死亡率的新风险评分。
Eur Heart J. 2022 Feb 12;43(7):654-662. doi: 10.1093/eurheartj/ehab679.
3
2021 ESC/EACTS Guidelines for the management of valvular heart disease.
2021年欧洲心脏病学会/欧洲心胸外科学会心脏瓣膜病管理指南。
Eur J Cardiothorac Surg. 2021 Oct 22;60(4):727-800. doi: 10.1093/ejcts/ezab389.
4
Initial Experience With the PASCAL Ace Implant System for Treatment of Severe Tricuspid Regurgitation.PASCAL Ace 植入系统治疗重度三尖瓣反流的初步经验。
Circ Cardiovasc Interv. 2021 Sep;14(9):e010770. doi: 10.1161/CIRCINTERVENTIONS.121.010770. Epub 2021 Aug 26.
5
Short-Term Clinical Outcomes of Transcatheter Tricuspid Valve Repair With the Third-Generation MitraClip XTR System.第三代 MitraClip XTR 系统经导管三尖瓣修复的短期临床结果。
JACC Cardiovasc Interv. 2021 Jun 14;14(11):1231-1240. doi: 10.1016/j.jcin.2021.03.033.
6
Valve Academic Research Consortium 3: Updated Endpoint Definitions for Aortic Valve Clinical Research.瓣膜学术研究联合会 3:主动脉瓣临床研究更新终点定义。
J Am Coll Cardiol. 2021 Jun 1;77(21):2717-2746. doi: 10.1016/j.jacc.2021.02.038. Epub 2021 Apr 19.
7
12-Month outcomes of transcatheter tricuspid valve repair with the PASCAL system for severe tricuspid regurgitation.经导管三尖瓣修复术治疗严重三尖瓣反流的 PASCAL 系统 12 个月的结果。
Catheter Cardiovasc Interv. 2021 May 1;97(6):1281-1289. doi: 10.1002/ccd.29583. Epub 2021 Mar 4.
8
Feasibility Study of the Transcatheter Valve Repair System for Severe Tricuspid Regurgitation.经导管三尖瓣修复系统治疗重度三尖瓣反流的可行性研究。
J Am Coll Cardiol. 2021 Feb 2;77(4):345-356. doi: 10.1016/j.jacc.2020.11.047.
9
Transcatheter Edge-to-Edge Repair for Treatment of Tricuspid Regurgitation.经导管缘对缘修复术治疗三尖瓣反流。
J Am Coll Cardiol. 2021 Jan 26;77(3):229-239. doi: 10.1016/j.jacc.2020.11.038.
10
Future Perspectives in Percutaneous Treatment of Tricuspid Regurgitation.经皮治疗三尖瓣反流的未来展望
Front Cardiovasc Med. 2020 Oct 14;7:581211. doi: 10.3389/fcvm.2020.581211. eCollection 2020.